Abstract
The Fcγ receptor IIIb (FcγRIIIb), a receptor for the Fcγ region of IgG, is specifically expressed on neutrophils. It has two allelic polymorphisms, NA1 and NA2, which are highly immunogenic and act as targets in alloimmune or autoimmune neutropenia. Thus, neutrophil antigens (NA) compatibility of donor/recipient pairs might be expected to affect the engraftment of neutrophils after allogeneic SCT (allo-SCT). Here, the impact of NA compatibility of 17 patients and their donors undergoing allo-SCT with a myeloablative regimen was determined. Leukocyte depletion filters were used for all transfusions before and post-SCT; most patients received G-CSF after transplant. Major mismatches for NA1 and NA2 were present in 1 and 7 patient/donor pairs, respectively. These eight patients receiving NA major-mismatched allo-SCT were compared with nine patients who received NA compatible allo-SCT. Engraftment of neutrophils and the incidence of post-engraftment neutropenia were found to be identical in the two groups. Despite the limitations in statistical power because of the small number of patients analyzed, these observations suggest that the major mismatching for NA2 antigen has little impact on the engraftment of neutrophils after myeloablative allo-SCT, at least in patients transfused using leukocyte depletion filters and receiving G-CSF after transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Klumpp TR . Antibody-mediated neutropenia following bone marrow transplantation. Int J Clin Lab Res 1993; 23: 4–7.
Klumpp TR, Herman JH, Mangan KF, Macdonald JS . Graft failure following neutrophil-specific alloantigen mismatched allogeneic BMT. Bone Marrow Transplant 1993; 11: 243–245.
Huizinga TW, Roos D, von dem Borne AE . Neutrophil Fcγ-receptors: a two-way bridge in the immune system. Blood 1990; 75: 1211–1214.
Scallon BJ, Scigliano E, Freedman VH, Miedel MC, Pan YCE, Unkeless JC et al. A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored froms. Proc Natl Acad Sci USA 1989; 86: 5079–5083.
Ory PA, Clark MR, Kwoh EE, Clarkson SB, Gorldstein IM . Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fcγ receptor III on human neutrophils. J Clin Invest 1989; 84: 1688–1691.
Cartron J, Tchernia G, Celton JL, Damay M, Cheron G, Farrokhi P et al. Alloimmune neonatal neutropenia. Am J Pediatr Hematol Oncol 1991; 13: 21–25.
Fromont P, Bettaieb A, Skouri H, Floch C, Poulet E, Duedari N et al. Frequency of the polymorphonuclear neutrophil Fcγ receptor III deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia. Blood 1992; 79: 2131–2134.
Shastri KA, Logue GL . Autoimmune neutropenia. Blood 1993; 81: 1984–1995.
Bux J, Behrens G, Jaeger G, Welte K . Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998; 91: 181–186.
Bruin MCA, von dem Borne AE, Tamminga RYJ, Kleijer M, Buddelmeijer L, de Haas M . Neutrophil antibody specific in different types of childhood autoimmune neutropenia. Blood 1999; 94: 1797–1802.
van der Veen JP, Hack CE, Engelfriet CP, Pegels JG, von dem Borne AE . Chronic idiopathic and secondary neutropenia: clinical and serological investigations. Br J Haematol 1986; 63: 161–171.
Huizinga TW, Kleijer M, Tetteroo PA, Roos D, von dem Borne AE . Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fcγ receptor III (CD16). Blood 1990; 75: 213–217.
de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE . Neutrophil Fcγ RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 1995; 86: 2403–2413.
Inukai T, Uno K, Taniguchi K, Goi K, Tezuka T, Nemoto A et al. Monitoring neutrophil engraftment in allogeneic stem cell transplantation by flow cytometric analysis of neutrophil-specific antigens NA1 and NA2. Br J Haematol 2007; 139: 280–283.
Klumpp TR, Herman JH, Schnell MK, Goldberg SL, Mangan KF . Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT. Bone Marrow Transplant 1996; 18: 559–564.
Warkentin PI, Clay ME, Kersey JH, Ramsay NK, McCullough J . Successful engraftment of NA1 positive bone marrow in a patient with a neutrophil antibody, anti-NA1. Hum Immunol 1981; 2: 173–184.
Tazzari PL, Rondelli D, Re F, Bandini G, Ricci F, Tassi C et al. Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantation. Eur J Haematol 1999; 62: 57–62.
Bishop MR, Tarantolo SR, Geller RB, Lynch JC, Bierman PJ, Pavletic ZS et al. A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. Blood 2000; 96: 80–85.
Przepiorka D, Smith TL, Folloder J, Anderlini P, Chan KW, Korbling M et al. Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors. Blood 2001; 97: 3405–3410.
Bedu A, Baumann C, Rohrlich P, Duval M, Fenneteau O, Cartron J . Failure of granulocyte colony-stimulating factor in alloimmune neonatal neutropenia. J Pediatr 1995; 127: 508–509.
Pocock CF, Lucas GF, Giles C, Vassiliou G, Cwynarski K, Rezvani K et al. Immune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies following unrelated donor stem cell transplantation for chronic myeloid leukaemia: perpetuation by granulocyte colony-stimulating factor. Br J Haematol 2001; 113: 483–485.
Gilmore MM, Stroncek DF, Korones DN . Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor. J Pediatr 1994; 125: 948–951.
Krishnan K, Ross CW, Bockenstedt PL, Adams PT . Successful treatment of autoimmune neutropenia with recombinant human granulocyte-colony stimulating factor (R-metHuG-CSF). Clin Lab Haematol 1997; 19: 105–109.
Bordin JO, Heddle NM, Blajchman MA . Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84: 1703–1721.
Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001; 98: 1687–1694.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Inukai, T., Goi, K., Tezuka, T. et al. Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCT. Bone Marrow Transplant 43, 229–235 (2009). https://doi.org/10.1038/bmt.2008.311
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.311
Keywords
This article is cited by
-
Tumor incidence in related hematopoietic stem cell donors
Bone Marrow Transplantation (2011)